Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-10-30
1998-11-03
Fitzgerald, David L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 530350, 530395, C07K 14715, A61K 3817, C12N 1512
Patent
active
058308474
ABSTRACT:
This invention provides a novel purified TGF-.beta.-binding glycoprotein, endoglin, an isolated nucleic acid molecule that encodes an amino acid sequence corresponding to the TGF-.beta.-binding glycoprotein, soluble endoglin-derived polypeptide, and fragments thereof. A pharmaceutical composition which comprises the endoglin-derived polypeptide purified by applicants or produced by applicants' recombinant methods and a pharmaceutically acceptable carrier is further provided as well as methods of treating patients which comprise administering to the patient the pharmaceutical composition of this invention.
REFERENCES:
patent: 5284931 (1994-02-01), Springer et al.
Bodmer et al., "Transforming Growth Factor-Beta Bound to Soluble Derivatives of the Beta Amylois Precursor Protein of Alzheimer's Disease" Biochem. Biophys. Res. Commun. 171(2):890-897 (1990).
Buhring et al., "Endoglin is Expressed on a Subpopulation of Immature Erythroid Cells of Normal Human Bone Marrow" Leukemia 5:841-847 (1991).
Cheifetz et al., "The Transforming Growth Factor-.beta. Receptor Type III Is a Membrane Proteoglycan" J. Biol. Chem. 263(32):16984-16991 (1988).
Cheifetz et al., "A Surface Component on GH.sub.3 Pituitary Cells That Recognizes Transforming Growth Factor-.beta., Activin, and Inhibin" J. Biol. Chem. 263(33):17225-17228 (1988).
Cheifetz et al., "Transforming Growth Factor-.beta. (TGF-.beta.) Receptor Proteoglycan" J. Biol. Chem. 264(20):12025-12028 (1989).
Cheifetz et al., "Isoform-specific Transforming Growth Factor-.beta.Binding Proteins with Membrane Attachments Sensitive to Phosphatidylinositol-specific Phospholipase C" J. Biol. Chem. 266(31):20767-20772 (1991).
Danielpour et al., "Differential Inhibition of Transforming Growth Factor .beta.1 and .beta.2 Activity by .sym..sub.1 -Macroglobulin" J. Biol. Chem. 265(12):6973-6977 (1990).
Fava et al., "Fibronectin-Associated Transforming Growth Factor" J. Cellular Physiology 131:184-189 (1987).
Gougos et al., "Identification of distinct epitopes of engoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts" International Imunology 4(1):83-92 (1992).
Gougos et al., "Identification of a Human Endothelial Cell Antigen With Monoclonal Antibody 44G4 Produced Against a Pre-B Leukemic Cell Line" J. of Immunology 141:1925-1933 (1988).
Gougos et al., "Biochemical Characterization of the 44G4 Antigen from the Hoon Pre-B Leukemic Cell Line" J. of Immunology 141:1934-1940 (1988).
Keski-Oja et al., "Transforming Growth Factors and Control of Neoplastic Cell Growth" J. Cellular Biochemistry 33:95-107 (1987).
LaMarre et al., ".alpha..sub.2 -Macroglobulin and Serum Preferentially Counteract the Mitoinhibitory Effect of Transforming Growth Factor-.beta.2 in Rat Hepatocytes" Laboratory Investigation 62(5):545-551 (1990).
Lastres et al., "Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen" Eur. J. Immunol. 22:393-397.
Lin et al., "Expression Cloning of the TGF-.beta. Type II Receptor, a Functional Transmembrane Serine/Threonine Kinase" Cell 68:775-785 (1992).
Lopez-Casillas et al., "Structure and Expression of the Membrane Proteoglycan Betaglycan, a Component of The TGF-.beta. Receptor System" Cell 67:785-795 (1991).
MacKay et al., "Identification of Disulfide-linked Transforming Growth Factor-.beta.1-specific Binding Proteins in Rat Glomeruli" J. Biol. Chem. 265(16):9351-9356 (1990).
MacKay et al., "Novel 150- and 180-kDa Glycoproteins That Bind Transforming Growth Factor (TGF)-.beta.1 but Not TGF-.beta.2 Are Present in Several Cell Lines" J. Biol. Chem. 266(15):9907-9911 (1991).
Massaque, Joan, "The TGF-.beta. Family of Growth and Differentiation Factors" Cell 49:437-438 (1987).
Massague, Joan, "The Transforming Growth Factor-.beta. Family" Annu. Rev. Cell Biol. 6:597-641 (1990).
Murphy-Ullrich et al., J. Cell. Biol. 111:148a (1990).
O'Connell et al., "Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation molecule" Clin. Exp. Immunol. 90:154-159 (1992).
O'Connor-McCourt et al., "Latent Transforming Growth Factor-.beta. in Serum" J. Biol. Chem. 262(29) 14090-14099 (1987).
O'Grady et al., "Purification of a New Type High Molecular Weight Receptor (Type V Receptor) of Transforming Growth Factor .beta. (TGF-.beta.) from Bovine Liver" J. Biol. Chem. 266(13):8583-8589 (1991).
Paralkar et al., Dev. Biol. 143:303-308 (1991).
Quackenbush et al., "Differential Localization Within Human Kidney of Five Membrane Proteins Expressed on Acute Lymphoblastic Leukemia Cells" J. of Immunology 136(1):118-124 (1988).
Quackenbush et al,. "Identification of Several Cell Surface Proteins of Non-T, Non-B Acute Lymphoblastic Leukemia By Using Monoclonal Antibodies" J. of Immunology 134(2):1276-1285 (1985).
Segarini et al., "The High Molecular Weight Receptor to Transforming Growth Factor-.beta. Contains Glycosaminoglycan Chains" J. Biol. Chem. 263(17):8366-8370 (1988).
Sporn et al., "Some Recent Advances in the Chemistry and Biology of Transforming Growth Factor-Beta" J. Cell Biology 105:1039-1045 (1987).
Wang et al., "Expression Cloning and Characterization of the TGF-.beta. Type III Receptor" Cell 67:797-805 (1991).
Yamaguchi et al., "Negative regulation of transforming growth factor-.beta. by the proteoglycan decorin" Nature 346:281-284 (1990).
Andres et al., J. Cell Biol. 109:31317-31345 (1989).
Gougos, A, et al (1990) J. Biol. Chem. 265: 8361-64.
Sutcliffe, J.G., et al (1983) Science 219: 660-66.
Letarte, M., et al. (1992) J. Cell Biochem. Suppl. O (16, pt. F): 158, abst. No. 214.
Cheifetz, S., et al. (1992) J. Biol. Chem. 267: 19027-30.
Bernabeu Carmelo
Cheifetz Sela
Letarte Michelle
Massague Joan
Fitzgerald David L.
HSC Research & Development Limited Partnership
LandOfFree
Soluble TGF-.beta.-binding endoglin polypeptides and homodimers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble TGF-.beta.-binding endoglin polypeptides and homodimers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble TGF-.beta.-binding endoglin polypeptides and homodimers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689059